Bivalent HPV Vaccine Effectiveness Correlates with Phylogenetic Distance from Hpv Vaccine Types 16 And 18.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Bogaards, Johannes Avan der Weele, Pascal
Woestenberg, Petra J
van Benthem, Birgit H B
King, Audrey J
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Bivalent HPV Vaccine Effectiveness Correlates with Phylogenetic Distance from Hpv Vaccine Types 16 And 18.Published in
J Infect Dis 2019; advance online publication (ahead of print)PMID
31165164ae974a485f413a2113503eed53cd6c53
10.1093/infdis/jiz280
Scopus Count
Collections
Related articles
- Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
- Authors: Woestenberg PJ, King AJ, van Benthem BHB, Donken R, Leussink S, van der Klis FRM, de Melker HE, van der Sande MAB, Hoebe CJPA, Bogaards JA, Medical Microbiological Laboratories and the Public Health Services.
- Issue date: 2018 Jan 4
- AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.
- Authors: McKeage K, Romanowski B
- Issue date: 2011 Mar 5
- Spotlight on AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®).
- Authors: McKeage K, Romanowski B
- Issue date: 2011 Aug 1
- Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.
- Authors: Gilca V, Sauvageau C, Panicker G, De Serres G, Ouakki M, Unger ER
- Issue date: 2018 Nov 12